{"id":"https://openalex.org/A5022645240","orcid":null,"observed_orcids":[],"display_name":"Ellen Tworkoski","raw_author_names":["Ellen Tworkoski"],"full_name":"Ellen Tworkoski","works_count":5,"cited_by_count":74,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":3,"i10_index":2},"ids":{"openalex":"https://openalex.org/A5022645240","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210101787","ror":"https://ror.org/01c0hdt76","display_name":"Acumen (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I4210101787"]},"years":[2024,2023,2022]}],"last_known_institutions":[{"id":"https://openalex.org/I4210101787","ror":"https://ror.org/01c0hdt76","display_name":"Acumen (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I4210101787"]}],"topics":[{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","count":2,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","count":2,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","count":2,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","count":2,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","count":2,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","value":1.54e-05,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10845","display_name":"Advanced Causal Inference Techniques","value":1e-05,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","value":8e-06,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","value":7.9e-06,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","value":6.1e-06,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.9266308546066284},{"id":"104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","score":0.8649739027023315},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.4384336769580841},{"id":"203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","score":0.3639077842235565},{"id":"98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","score":0.2644640803337097}],"counts_by_year":[{"year":2019,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2022,"works_count":2,"oa_works_count":2,"cited_by_count":0},{"year":2023,"works_count":1,"oa_works_count":0,"cited_by_count":17},{"year":2024,"works_count":1,"oa_works_count":1,"cited_by_count":21},{"year":2025,"works_count":0,"oa_works_count":0,"cited_by_count":21},{"year":2026,"works_count":0,"oa_works_count":0,"cited_by_count":15}],"display_name_alternatives":["Ellen Tworkoski"],"block_key":"e tworkoski","works_api_url":"https://api.openalex.org/works?filter=author.id:A5022645240","awards_count":0,"updated_date":"2026-11-04T11:47:51","created_date":"2020-02-07T00:00:00"}